MONTREAL, QUEBEC--(Marketwire - February 11, 2009) - Adaltis Inc. (TSX: ADS), an international in vitro diagnostic company, announced the appointment of Mr. Erez Barnavon to the Board of Directors of the Company and as a member of the Corporate Governance Committee, the Compensation Committee and the Nominating Committee, effective February 6, 2009.
Mr. Erez Barnavon is Senior Vice President with Clarity Partners L.P.
Mr. Barnavon’s appointment fills the vacancy created from the resignation of Mr. Kevin Guanghao Lu from the Board of Directors, effective February 6, 2009. The Board wishes to thank Mr. Lu for his contribution to the Company.
As a result of these changes, the current Board of Directors of Adaltis is composed of: Mrs. Michelle Cormier (Chairman), Mr. Peter Bambic, Mr. Erez Barnavon, Mr. Peter Kruyt, Mr. Pierre Larochelle, Mr. Chen-Chong Tay and Mr. Victor Yang.
About Adaltis Inc.
Adaltis is an international in vitro diagnostic company with a mission to become a leading provider of in vitro diagnostic products in emerging markets, with a particular focus on China.
With the strategic advantage of its “state of the art” reagent manufacturing facility located in Shanghai, China, a complete IVD product offering targeting emerging markets, and a strong international sales and distribution platform, Adaltis is able to manufacture high-quality products in a low-cost GMP environment, in order to service existing markets in Europe, while providing a platform to penetrate the high-growth Chinese in vitro diagnostic market.
Adaltis is headquartered in Montreal, with offices in China, India, Italy and Mexico.
Contacts:
Adaltis Inc.
Mrs. Michelle Cormier
Chairman of the Board
514-335-9922, ext. 241
